1. Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first‐line intensified treatment of pediatric patients with high‐risk acute lymphoblastic leukemia in CoALL08‐09 trial. Issue 12 (21st September 2022) Authors: Mezger, Kerstin; Ebert, Sabine; Muhle, Hannah Elisa; Stadt, Udo zur; Borkhardt, Arndt; Dilloo, Dagmar; Faber, Jörg; Feuchtinger, Tobias; Imschweiler, Thomas; Jorch, Norbert; Pekrun, Arnulf; Schmid, Irene; Schramm, Franziska; Zimmermann, Martin; Horstmann, Martin A; Escherich, Gabriele Journal: Pediatric blood & cancer Issue: Volume 69:Issue 12(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brentuximab vedotin exerts profound antiproliferative and pro‐apoptotic efficacy in CD30‐positive as well as cocultured CD30‐negative germ cell tumour cell lines. Issue 1 (22nd September 2017) Authors: Schönberger, Stefan; van Beekum, Cornelius; Götz, Barbara; Nettersheim, Daniel; Schorle, Hubert; Schneider, Dominik T.; Casati, Anna; Craveiro, Rogerio B.; Calaminus, Gabriele; Dilloo, Dagmar Journal: Journal of cellular and molecular medicine Issue: Volume 22:Issue 1(2018) Page Start: 568 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Haematological malignancies following temozolomide treatment for paediatric high-grade glioma. (August 2017) Authors: Karremann, Michael; Krämer, Nadja; Hoffmann, Marion; Wiese, Maria; Beilken, Andreas; Corbacioglu, Selim; Dilloo, Dagmar; Driever, Pablo Hernáiz; Scheurlen, Wolfram; Kulozik, Andreas; Gielen, Gerrit H.; von Bueren, André O.; Dürken, Matthias; Kramm, Christof M. Journal: European journal of cancer Issue: Volume 81(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Health status, health-related quality of life, and socioeconomic outcome in childhood brain tumor survivors: a German cohort study. Issue 8 (22nd February 2019) Authors: Scholtes, Cathy; Baust, Katja; Weinhold, Leonie; Creutzig, Ursula; Gnekow, Astrid; Hinz, Andreas; Kaatsch, Peter; Kreitz, Kiana; Langer, Thorsten; Rutkowski, Stefan; Singer, Susanne; Spix, Claudia; Teske, Carmen; Schmid, Matthias; Dilloo, Dagmar; Calaminus, Gabriele Journal: Neuro-oncology Issue: Volume 21:Issue 8(2019) Page Start: 1069 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Successful ECMO therapy in a child with COVID‐19‐associated ARDS and acute lymphoblastic leukemia. Issue 9 (22nd May 2021) Authors: Ebach, Fabian; Hainmann, Ina; Eis‐Hübinger, Anna M.; Escherisch, Gabriele; Dilloo, Dagmar; Reutter, Heiko M.; Müller, Andreas Journal: Pediatric blood & cancer Issue: Volume 68:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia. Issue 11 (9th May 2014) Authors: Moser, Olga; Krumbholz, Manuela; Thiede, Christian; Tauer, Josephine T.; Janz, Indra; Lauten, Melchior; Dilloo, Dagmar; Metzler, Markus; Suttorp, Meinolf Journal: Pediatric blood & cancer Issue: Volume 61:Issue 11(2014:Nov.) Page Start: 2080 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The FDA approved PI3K inhibitor GDC‐0941 enhances in vitro the anti‐neoplastic efficacy of Axitinib against c‐myc‐amplified high‐risk medulloblastoma. Issue 4 (29th January 2018) Authors: Ehrhardt, Michael; Craveiro, Rogerio B.; Velz, Julia; Olschewski, Martin; Casati, Anna; Schönberger, Stefan; Pietsch, Torsten; Dilloo, Dagmar Journal: Journal of cellular and molecular medicine Issue: Volume 22:Issue 4(2018) Page Start: 2153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The PI3K inhibitor pictilisib and the multikinase inhibitors pazopanib and sorafenib have an impact on Rac1 level and migration of medulloblastoma in vitro. Issue 23 (15th November 2022) Authors: Schoen, Leonie F.; Craveiro, Rogerio B.; Pietsch, Torsten; Moritz, Thomas; Troeger, Anja; Jordans, Silvia; Dilloo, Dagmar Journal: Journal of cellular and molecular medicine Issue: Volume 26:Issue 23(2022) Page Start: 5832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗